Victoria Field
Victoria Field is an accomplished science communicator, entrepreneur, and innovative leader in the field of metabolic health, with more than a decade of experience advancing the science, education, and clinical application of metabolic therapy. She is the Co-Founder and CEO of Metabolic Health Initiative (MHI), an ACCME-accredited medical education organization advancing the global conversation on metabolism in chronic disease through CME content (The Metabolic Initiative), a medical and science-focused podcast (The Metabolic Link), and the world’s premier scientific conference on metabolic health and therapy (Metabolic Health Summit). Earlier in her career, she served as the program director of Epigenix Foundation, where she played a pivotal role in leading pilot studies that translated ketogenic metabolic therapy into clinical practice—working directly with cancer patients and in collaboration with oncologists, veterinarians, and world-renowned institutions such as Cedars-Sinai. Victoria brings a rare combination of scientific insight, media and business expertise, and firsthand experience applying a metabolic approach to reversing disease—fueling her mission to bring transformative science to the frontlines of healthcare and reimagine how we prevent and treat chronic illness.
With over a decade of experience at the intersection of metabolic research, medical education, and public health, Victoria Field has a rare ability to bridge cutting-edge science with real-world application—delivering evidence-based, metabolism-centered solutions that target the root causes of cancer and chronic disease.
Awards
- Oregon Association of Broadcasters Award (Excellence in Public Communication)
- Cascade Business News “Accomplished Under 40” (Leadership in Innovation & Education)
Years of Clinical Experience & Estimated Number of Patients Treated
Victoria’s work focuses on research translation, medical education, and empowering patients and professionals through science-based digital platforms and live events. Her initiatives have influenced tens of thousands of clinicians, researchers, policymakers, and patients worldwide, and supported healthcare providers in applying ketogenic metabolic therapy to address chronic disease in clinical practice.